<i>Jiawei Kongsheng Zhenzhong Pill</i> (JKZP) Alleviates Chronic Cerebral Hypoperfusion‐Induced Hippocampal Synaptic Damage via S100A10/tPA/BDNF Pathway
These results manifested that JKZP promoted neurological recovery after chronic cerebral ischemia by alleviating synaptic damage and activating the S100A10/tPA/BDNF pathway, thereby providing a novel perspective and a solid foundation against MCI.
Authors
- Zhichun Wu (ORCID: https://orcid.org/0000-0003-1702-4853)
- Hua-Yun Yu (ORCID: https://orcid.org/0000-0003-4837-7846)
- Zu Gao (ORCID: https://orcid.org/0000-0002-4500-9784)
- Yang Zhou (ORCID: https://orcid.org/0000-0002-9217-5208)
- Yuan Wang (ORCID: https://orcid.org/0000-0002-0939-1269)
- Xiaolin Wu (ORCID: https://orcid.org/0000-0002-6308-151X)
- Qiaolan Wu
- Yue Zhao
- Chunxue Ou
Institutions
- Shandong University of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- Brain and Behavior
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1002/brb3.70328
- Citations
- 4
- Primary Topic
- Neurological Disease Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 3.37
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province